Varenicline for Adolescent Smoking Cessation

Completed · Phase 3 · Has a placebo group

Conditions studied: Nicotine Dependence

In brief

This is a placebo-controlled smoking cessation treatment study for adolescents ages 14-21. After assessment and inclusion into the study, participants will be randomized to receive a 12-week double blind course of varenicline or placebo.

Key facts

Study ID
NCT01509547
Run by
Medical University of South Carolina
People needed
157
Starts
2012-08-01
Expected to finish
2018-01-26
Last updated by the study team
2020-07-01

Who can join

Age: 14 and older, up to 21. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.